The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Marty Makary's Industry Ties Raise Concerns Ahead of FDA Confirmation Hearings
Dr. Marty Makary, nominated as FDA commissioner, faces scrutiny over his ties to the pharmaceutical industry, including a director position at Harrow and advisory roles with various health organizations. His connections may raise concerns during Senate confirmation hearings, especially as the FDA navigates issues surrounding GLP-1 medications. The history of FDA commissioners transitioning to industry roles adds to the debate on potential conflicts of interest in public health decisions.
trump's health agency nominees raise global public health concerns
Concerns are rising globally over Donald Trump's healthcare nominees, particularly regarding their potential "anti-science" views and the impact on public health funding. His administration's past actions, such as severing ties with the WHO and defunding programs aligned with reproductive rights, have heightened these fears. Experts warn that the appointment of individuals skeptical of science could diminish the credibility of U.S. health agencies and affect global health strategies.
euralink launches new trial for brain implant to control robotic arm
Neuralink has initiated its "CONVOY Study" to determine if its brain-computer interface (BCI) can enable patients to control a robotic arm, following the "PRIME Study" which assessed safety and utility. Two human patients have already been implanted, and recruitment for a new trial in Canada is underway for those with quadriplegia. The company continues to face competition in the BCI field, with no FDA-approved devices for commercialization yet.
hims and hers shares soar on trump fda pick support
Hims & Hers Health Inc. shares surged by up to 18%, reaching record highs, following the news of President-elect Donald Trump nominating Marty Makary to lead the FDA. Hunterbrook Media highlighted that Makary could be a significant ally for the company, which is involved in selling compounded GLP-1 weight loss drugs. Hunterbrook Capital has shifted its position to long Hims shares, reversing a previous short bet.
Trump nominates Marty Makary to lead FDA amid health policy controversies
Donald Trump has nominated Marty Makary, a surgeon and critic of pandemic measures, to lead the FDA, aiming to restore its scientific integrity and reduce regulatory burdens. Makary, known for his skepticism towards the pharmaceutical industry and vaccine mandates, would oversee an agency responsible for the safety of a vast array of consumer products. His confirmation would align him with Robert F. Kennedy Jr., who leads the Department of Health and Human Services, despite differing views on vaccines.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.